Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Research & Development (2016 - 2025)

Historic Research & Development for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $2.9 million.

  • Ultralife's Research & Development rose 3588.77% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 2965.22%. This contributed to the annual value of $8.3 million for FY2024, which is 978.62% up from last year.
  • Latest data reveals that Ultralife reported Research & Development of $2.9 million as of Q3 2025, which was up 3588.77% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Research & Development registered a high of $2.9 million during Q3 2025, and its lowest value of $1.6 million during Q1 2021.
  • Its 4-year average for Research & Development is $2.1 million, with a median of $2.0 million in 2024.
  • As far as peak fluctuations go, Ultralife's Research & Development skyrocketed by 4533.33% in 2021, and later tumbled by 1358.27% in 2024.
  • Quarter analysis of 4 years shows Ultralife's Research & Development stood at $1.9 million in 2021, then fell by 0.05% to $1.9 million in 2023, then soared by 30.35% to $2.4 million in 2024, then grew by 18.27% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $2.3 million for Q2 2025, and $2.4 million during Q1 2025.